Drug General Information |
Drug ID |
DXIA0J
|
Drug Name |
2,3-di(furan-2-yl)quinoxaline
|
Synonyms |
CHEMBL305978
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Formula |
C16H10N2O2
|
Canonical SMILES |
o1cccc1c2nc3ccccc3nc2c4occc4
|
InChI |
InChI=1S/C16H10N2O2/c1-2-6-12-11(5-1)17-15(13-7-3-9-19-13)16(18-12)14-8-4-10-20-14/h1-10H
|
InChIKey |
GMUROSQCXMKHEN-UHFFFAOYSA-N
|
Target and Pathway |
Target(s) |
Estrogen receptor beta |
Target Info |
|
[1]
|
Induced myeloid leukemia cell differentiation protein Mcl-1 |
Target Info |
|
[1]
|
KEGG Pathway
|
Estrogen signaling pathway
|
Prolactin signaling pathwayhsa04151:PI3K-Akt signaling pathway
|
MicroRNAs in cancer
|
NetPath Pathway
|
TCR Signaling Pathway
|
PANTHER Pathway
|
Apoptosis signaling pathway
|
CCKR signaling map ST
|
Pathway Interaction Database
|
Plasma membrane estrogen receptor signaling
|
Validated nuclear estrogen receptor beta network
|
Validated nuclear estrogen receptor alpha networke2f_pathway:E2F transcription factor network
|
Direct p53 effectors
|
IL6-mediated signaling events
|
HIF-1-alpha transcription factor network
|
Reactome
|
Nuclear Receptor transcription pathway
|
WikiPathways
|
SIDS Susceptibility Pathways
|
Ovarian Infertility Genes
|
Integrated Pancreatic Cancer Pathway
|
Nuclear ReceptorsWP254:Apoptosis
|
miR-targeted genes in muscle cell - TarBase
|
miR-targeted genes in lymphocytes - TarBase
|
miR-targeted genes in leukocytes - TarBase
|
Apoptosis Modulation and Signaling
|
References |
REF 1 | URL: https://www.ebi.ac.uk/chembl/ The ChEMBL database in 2017 |